TipRanks
Advertisement
Advertisement
MyMD Pharmaceuticals appoints Mitchell Glass as chief medical officer
PremiumThe FlyMyMD Pharmaceuticals appoints Mitchell Glass as chief medical officer
2y ago
MyMD Pharmaceuticals secures $7M investment from PharmaCyte Biotech
Premium
The Fly
MyMD Pharmaceuticals secures $7M investment from PharmaCyte Biotech
2y ago
MyMD Pharmaceuticals Enhances Governance and Financing Structure
Premium
Company Announcements
MyMD Pharmaceuticals Enhances Governance and Financing Structure
3y ago
MyMD Pharmaceuticals announces 1-for-30 reverse stock split
PremiumThe FlyMyMD Pharmaceuticals announces 1-for-30 reverse stock split
3y ago
MyMD Pharmaceuticals announces results from Supera-CBD study
Premium
The Fly
MyMD Pharmaceuticals announces results from Supera-CBD study
3y ago
MyMD Pharma to present  ‘statistically’ significant Phase 2 data for MYMD-1
Premium
The Fly
MyMD Pharma to present ‘statistically’ significant Phase 2 data for MYMD-1
3y ago
MyMD Pharmaceuticals gives dosing update on Phase 2 of MYMD-1 trial
PremiumThe FlyMyMD Pharmaceuticals gives dosing update on Phase 2 of MYMD-1 trial
4y ago
MyMD Pharmaceuticals presents data from MYMD-1 preclinical study
Premium
The Fly
MyMD Pharmaceuticals presents data from MYMD-1 preclinical study
4y ago
MyMD Pharmaceuticals: DEA determines Supera-CBD not a controlled substance
Premium
The Fly
MyMD Pharmaceuticals: DEA determines Supera-CBD not a controlled substance
4y ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―